Insights into the molecular evolution of oxytocin receptor ligand binding

Biochemical Society Transactions

Volumn 41, Issue 1, 2013, Pages 197-204

  Koehbach, Johannes ^a   Stockner, Thomas ^a   Bergmayr, Christian ^a   Muttenthaler, Markus ^b   Gruber, Christian W ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Arginine vasopressin; Binding; GPCR (G protein coupled receptor); Homology model; OT (oxytocin); Vasotocin

Indexed keywords

ARGIPRESSIN; ARGIPRESSIN RECEPTOR; G PROTEIN COUPLED RECEPTOR; OXYTOCIN; OXYTOCIN RECEPTOR; PEPTIDE DERIVATIVE; RECEPTOR SUBTYPE;

AMINO ACID SEQUENCE; BINDING AFFINITY; BINDING SITE; COMPUTER MODEL; CONFERENCE PAPER; CRYSTAL STRUCTURE; DRUG DESIGN; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; HUMAN; LIGAND BINDING; MOLECULAR EVOLUTION; MOLECULAR INTERACTION; MOLECULAR MODEL; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; EVOLUTION, MOLECULAR; HUMANS; LIGANDS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; RECEPTORS, OXYTOCIN;

EID: 84873193538     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20120256     Document Type: Conference Paper

References (37)

1. Gruber, C. W., Muttenthaler, M. and Freissmuth, M. (2010) Ligand-based peptide design and combinatorial peptide libraries to target G protein-coupled receptors. Curr. Pharm. Des. 16, 3071-3088
2. Gimpl, G. and Fahrenholz, F. (2001) The oxytocin receptor system: structure, function, and regulation. Physiol. Rev. 81, 629-683 (Pubitemid 32267075)
3. Gruber, C. W., Koehbach, J. and Muttenthaler, M. (2012) Exploring bioactive peptides from natural sources for oxytocin and vasopressin drug discovery. Future Med. Chem. 4, 1791-1798
4. Manning, M., Misicka, A., Olma, A., Bankowski, K., Stoev, S., Chini, B., Durroux, T., Mouillac, B., Corbani, M. and Guillon, G. (2012) Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics. J. Neuroendocrinol. 24, 609-628
5. Donaldson, Z. R. and Young, L. J. (2008) Oxytocin, vasopressin, and the neurogenetics of sociality. Science 322, 900-904
6. Gruber, C. W. and Muttenthaler, M. (2012) Discovery of defense-and neuropeptides in social ants by genome-mining. PLoS ONE 7, 20
7. Chini, B. and Manning, M. (2007) Agonist selectivity in the oxytocin/vasopressin receptor family: new insights and challenges. Biochem. Soc. Trans. 35, 737-741 (Pubitemid 47310357)
8. Acher, R. and Chauvet, J. (1995) The neurohypophysial endocrine regulatory cascade: precursors, mediators, receptors, and effectors. Front. Neuroendocrinol. 16, 237-289
9. Goodson, J. L. (2008) Nonapeptides and the evolutionary patterning of sociality. Prog. Brain Res. 170, 3-15 (Pubitemid 352010216)
10. Wesley, V. J., Hawtin, S. R., Howard, H. C. and Wheatley, M. (2002) Agonist-specific, high-affinity binding epitopes are contributed by an arginine in the N-terminus of the human oxytocin receptor. Biochemistry 41, 5086-5092 (Pubitemid 34411662)
11. Wheatley, M., Hawtin, S. R., Wesley, V. J., Howard, H. C., Simms, J., Miles, A., McEwan, K. and Parslow, R. A. (2003) Agonist binding to peptide hormone receptors. Biochem. Soc. Trans. 31, 35-39 (Pubitemid 36241393)
12. Chini, B., Mouillac, B., Ala, Y., Balestre, M. N., Trumpp-Kallmeyer, S., Hoflack, J., Elands, J., Hibert, M., Manning, M. and Jard, S. (1995) Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor. EMBOJ. 14, 2176-2182
13. Chini, B., Mouillac, B., Ala, Y., Balestre, M. N., Trumpp-Kallmeyer, S., Hoflack, J., Elands, J., Hibert, M., Manning, M., Jard, S. and Barberis, C. (1997) Identification of a single residue responsible for agonist selectivity in the oxytocin-vasopressin receptors. Ann. N. Y. Acad. Sci. 812, 218-221 (Pubitemid 27309719)
14. Chini, B., Mouillac, B., Balestre, M.-N., Trumpp-Kallmeyer, S., Hoflack, J., Hibert, M., Andriolo, M., Pupier, S., Jard, S. and Barberis, C. (1996) Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin. FEBS Lett. 397, 201-206 (Pubitemid 26414017)
15. Zingg, H. H. and Laporte, S. A. (2003) The oxytocin receptor. Trends Endocrinol. Metab. 14, 222-227 (Pubitemid 36841480)
16. aq coupling specificity. Mol. Endocrinol. 16, 814-823 (Pubitemid 34297749)
17. Fanelli, F., Barbier, P., Zanchetta, D., de Benedetti, P. G. and Chini, B. (1999) Activation mechanism of human oxytocin receptor: a combined study of experimental and computer-simulated mutagenesis. Mol. Pharmacol. 56, 214-225 (Pubitemid 29309831)
18. Manning, M., Stoev, S., Chini, B., Durroux, T., Mouillac, B. and Guillon, G. (2008) Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents. Prog. Brain Res. 170, 473-512 (Pubitemid 352014896)
19. Granier, S., Manglik, A., Kruse, A. C., Kobilka, T. S., Thian, F. S., Weis, W. I. and Kobilka, B. K. (2012) Structure of the δ-opioid receptor bound to naltrindole. Nature 485, 400-404
20. Manglik, A., Kruse, A. C., Kobilka, T. S., Thian, F. S., Mathiesen, J. M., Sunahara, R. K., Pardo, L., Weis, W. I., Kobilka, B. K. and Granier, S. (2012) Crystal structure of the micro-opioid receptor bound to a morphinan antagonist. Nature 485, 321-326
21. Haga, K., Kruse, A. C., Asada, H., Yurugi-Kobayashi, T., Shiroishi, M., Zhang, C, Weis, W. I., Okada, T., Kobilka, B. K., Haga, T. and Kobayashi, T. (2012) Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist. Nature 482, 547-551
22. Jaakola, V. P., Griffith, M. T., Hanson, M. A., Cherezov, V., Chien, E. Y., Lane, J. R., Ijzerman, A. P. and Stevens, R. C. (2008) The 2.6 Å crystal structure of a human A2a adenosine receptor bound to an antagonist. Science 322, 1211-1217
23. Shimamura, T., Shiroishi, M., Weyand, S., Tsujimoto, H., Winter, G., Katritch, V., Abagyan, R., Cherezov, V., Liu, W., Han, G. W. et al. (2011) Structure of the human histamine H1 receptor complex with doxepin. Nature 475, 65-70
24. Wu, H., Wacker, D., Mileni, M., Katritch, V., Han, G. W., Vardy, E., Liu, W., Thompson, A. A., Huang, X. P., Carroll, F. I. et al. (2012) Structure of the human κ-opioid receptor in complex with JDTic. Nature 485, 327-332
25. Wu, B., Chien, E. Y., Mol, CD., Fenalti, G., Liu, W., Katritch, V., Abagyan, R., Brooun, A., Wells, P., Bi, F. C. et al. (2010) Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 330, 1066-1071
26. Thompson, A. A., Liu, W., Chun, E., Katritch, V., Wu, H., Vardy, E., Huang, X. P., Trapella, C, Guerrini, R., Calo, G. et al. (2012) Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic. Nature 485, 395-399
27. Hanson, M. A., Roth, C. B., Jo, E., Griffith, M. T., Scott, F. L, Reinhart, G., Desale, H., Clemons, B., Cahalan, S. M. and Schuerer, S. C. (2012) Crystal structure of a lipid G protein-coupled receptor. Science 335, 851-855
28. 2A adenosine receptor. Science 332, 322-327
29. Granier, S. and Kobilka, B. (2012) A new era of GPCR structural and chemical biology. Nat. Chem. Biol. 8, 670-673
30. a White, J. F., Noinaj, N., Shibata, Y., Love, J., Kloss, B., Xu, F., Gvozdenovic-Jeremic, J., Shah, P., Shiloach, J., Tate, C. G. and Grisshammer, R. (2012) Structure of the agonist-bound neurotensin receptor. Nature 490, 508-513
31. Slusarz, M. J., Slusarz, R. and Ciarkowski, J. (2006) Molecular dynamics simulation of human neurohypophyseal hormone receptors complexed with oxytocin-modeling of an activated state. J. Pept. Sci. 12, 171-179 (Pubitemid 43349357)
32. van Kesteren, R. E. and Geraerts, W. P. (1998) Molecular evolution of ligand-binding specificity in the vasopressin/oxytocin receptor family. Ann. N. Y. Acad. Sci. 839, 25-34 (Pubitemid 28301756)
33. Cho, H. J., Acharjee, S., Moon, M. J., Oh, D. Y., Vaudry, H., Kwon, H. B. and Seong, J. Y. (2007) Molecular evolution of neuropeptide receptors with regard to maintaining high affinity to their authentic ligands. Gen. Comp. Endocrinol. 153, 98-107 (Pubitemid 47102319)
34. Edgar, R. C. (2004) MUSCLE: a multiple sequence alignment method with reduced time and space complexity. BMC Bioinf. 5, 113
35. Sali, A. and Blundell, T. L. (1993) Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234, 779-815 (Pubitemid 24007801)
36. Beets, I., Janssen, T., Meelkop, E., Temmerman, L., Suetens, N., Rademakers, S., Jansen, G. and Schoofs, L. (2012) Vasopressin/oxytocin-related signaling regulates gustatory associative learning in C. elegans. Science 338, 543-545
37. Garrison, J. L., Macosko, E. Z., Bernstein, S., Pokala, N., Albrecht, D. R. and Bargmann, C. I. (2012) Oxytocin/vasopressin-related peptide have an ancient role in reproductive behavior. Science 338, 540-543